Back to Results
First PageMeta Content
Organic chemistry / Health / HIV/AIDS / Amides / Oxadiazoles / Raltegravir / Lamivudine / GlaxoSmithKline / Dolutegravir / Organofluorides / Chemistry / Integrase inhibitors


  Once‐Daily Dolutegravir is Non‐Inferior to Twice‐Daily Raltegravir  in Treatment‐Naïve Adults with HIV‐1    
Add to Reading List

Document Date: 2014-11-03 11:26:21


Open Document

File Size: 171,17 KB

Share Result on Facebook
UPDATE